{"id":9686,"date":"2023-10-30T08:01:01","date_gmt":"2023-10-30T07:01:01","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=9686"},"modified":"2023-10-30T09:19:07","modified_gmt":"2023-10-30T08:19:07","slug":"atlas-mapping-the-global-burden-of-atopic-dermatitis","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2023\/10\/30\/atlas-mapping-the-global-burden-of-atopic-dermatitis\/","title":{"rendered":"Atlas mapping the global burden of atopic dermatitis"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n

30 October 2023<\/em><\/p>\n\n\n\n

How many people suffer from atopic dermatitis? At what age? How severe is it? And how is it treated? With strong data, we will better understand the global and local disease burden of atopic dermatitis, ultimately improving care and support for those affected. With a DKK 10 million grant from the LEO Foundation, the Global Atopic Dermatitis Atlas aims to become a<\/strong> leading open resource, where global and validated data on atopic dermatitis is available in one place.<\/strong> <\/p>\n\n\n\n

Atopic dermatitis, also called atopic eczema, or just eczema, is a non-contagious, chronic skin disease, causing dry, patchy, and itchy skin. It affects up to 20% of children and up to 10% of adults. Of all skin diseases worldwide, it is the most common type, with a burden that remains a significant challenge for the people affected, their families, and societies.  <\/p>\n\n\n\n

Despite progress made in treating severe forms of atopic dermatitis, there is a need for high-quality information showing how many people per country have atopic dermatitis and how severe it is. With strong data, atopic dermatitis can be better understood and treated. <\/p>\n\n\n\n

With a grant of DKK 10 million (EUR 1.3 million) from the LEO Foundation, the Global Atopic Dermatitis Atlas, or GADA, will help address gaps in current data by creating and maintaining a living online atlas, where the newest research-based knowledge and data on atopic dermatitis, its prevalence, severity, and treatment are available in one place – collected and analyzed in the same way for all countries. <\/p>\n\n\n\n

An international collaboration<\/strong><\/p>\n\n\n\n

GADA is an international collaboration between the International League of Dermatological Societies (ILDS), the International Eczema Council (IEC), the International Society of Atopic Dermatitis (ISAD), the European Taskforce for Atopic Dermatitis (ETFAD), and the Global Alliance of Dermatology Patient Organizations (IADPO\/GlobalSkin).<\/p>\n\n\n\n

GADA is led by Professor Carsten Flohr, Chair in Dermatology and Population Health Sciences at King\u2019s College London, and it builds on a collaboration between 13 researchers and experts from all over the world.<\/p>\n\n\n\n

Professor Carsten Flohr, Director of GADA, says: <\/p>\n\n\n\n

\u201cThe support from the LEO Foundation will enhance our ability to continue to collect and analyze burden data on atopic dermatitis globally. Our goal is to create a comprehensive atlas that provides critical insights into the prevalence, severity, and treatment of atopic dermatitis, filling the gaps in our understanding.\u201d\u202f<\/p>\n\n\n\n

<\/div>\n\n\n
\n
\n
\n
\n